Following an application from CSL - Centro Sperimentale del Latte S.p.A., submitted pursuant to Article 14(1)(b) of Regulation (EC) No 1924/2006, the Authority was required to deliver an opinion on a health claim related to the effects of a combination of Lactobacillus delbrueckii subsp. bulgaricus strain AY/CSL (LMG P-17224) and Streptococcus thermophilus strain 9Y/CSL (LMG P-17225) on beneficial modulation of intestinal microflora (Question No EFSA-Q-2008-273) [The EFSA Journal 2011; 9(7):2288.]. The claim proposed by the applicant was worded as follows: "Maintaining the gut health by normalizing the intestinal flora".
Recital 9, Commission Regulation (EU) No 378/2012 of 3 May 2012 refusing to authorise certain healt…
In forcesince 3 May 2012